AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1595918 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (1 microgram/kg)
Number of subjects: 154
Study 1595918 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (2 micrograms/kg)
Number of subjects: 154
Study 1595918 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (4 micrograms/kg)
Number of subjects: 154
Study 1595918 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl (1, 2, or 4 micrograms/kg)
Number of subjects: 154
Study 1595918 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (epidural)
Number of subjects: 154
Study 6362814 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC + BCG
Number of subjects: 238
Study 6362814 — intervention group
Group type: COMPARATOR
Intervention: FAC alone
Number of subjects: 238
Study 6362814 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC with irradiation
Number of subjects: 238
Study 6362814 — intervention group
Group type: COMPARATOR
Intervention: FAC without irradiation
Number of subjects: 238
Study 31003650 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation after discharge
Number of subjects: 228
Study 31003650 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 228
Study 30410937 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma A42 level in AD patients
Number of subjects: 58
Study 30410937 — intervention group
Group type: COMPARATOR
Intervention: Plasma A42 level in control group
Number of subjects: 58
Study 30410937 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF A levels in AD patients
Number of subjects: 58
Study 30410937 — intervention group
Group type: COMPARATOR
Intervention: CSF A levels in control group
Number of subjects: 58
Study 26553256 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture adhesives
Number of subjects: 49
Study 23756935 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive interface
Number of subjects: 0
Study 23756935 — intervention group
Group type: COMPARATOR
Intervention: Standard interface
Number of subjects: 0
Study 23756935 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology (both interfaces)
Number of subjects: 0
Study 23756935 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer collaboration
Number of subjects: 0
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: TAXUS paclitaxel‐eluting stent (PES)
Number of subjects: 501
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of interleukin‐6 (IL‐6) at admission
Number of subjects: 501
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: Low admission levels of cardiotrophin‐1 (CT‐1)
Number of subjects: 501
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower values of IL‐1ra, MMP9, and MPO at 30 days
Number of subjects: 501
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: Decline in IL‐1ra, MCP‐1, and MMP9 from admission to 30 days
Number of subjects: 501
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: Low values of IL‐6 at 30 days
Number of subjects: 501
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: MPO at 30 days
Number of subjects: 501
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: Decline of MCP‐1 between admission and 30 days
Number of subjects: 501
Study 22466810 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐1
Number of subjects: 501
Study 20706733 — intervention group
Group type: EXPERIMENTAL
Intervention: Single training session (STS) at 60° s(‐1)
Number of subjects: 17
Study 20706733 — intervention group
Group type: EXPERIMENTAL
Intervention: Single training session (STS) at 180° s(‐1)
Number of subjects: 17
Study 20706733 — intervention group
Group type: EXPERIMENTAL
Intervention: Single training session (STS) at both velocities
Number of subjects: 17
Study 18590560 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 0
Study 18590560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15908177 — intervention group
Group type: EXPERIMENTAL
Intervention: Astronauts' monocytes after 5-11 days of spaceflight
Number of subjects: 34
Study 15908177 — intervention group
Group type: EXPERIMENTAL
Intervention: Astronauts' monocytes after spaceflight
Number of subjects: 34
Study 15908177 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-astronauts)
Number of subjects: 34
Study 15908177 — intervention group
Group type: EXPERIMENTAL
Intervention: Levels of cortisol, epinephrine, and norepinephrine after spaceflight
Number of subjects: 34
Study 12714861 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 4964
Study 12714861 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 4964
Study 10352397 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human GH (0.18 U/kg IBW/week)
Number of subjects: 24
Study 10352397 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle injection)
Number of subjects: 24
Study 8748889 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (2 tablets daily)
Number of subjects: 104
Study 8748889 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (1 tablet daily)
Number of subjects: 104
Study 8748889 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (4 tablets daily)
Number of subjects: 104
Study 1981017 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (5 mg od)
Number of subjects: 24
Study 1981017 — intervention group
Group type: COMPARATOR
Intervention: Captopril (25 mg bid)
Number of subjects: 24
Study 1981017 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 24
Study 1981017 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 24
Study 6163573 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (5 mg, two tablets)
Number of subjects: 5
Study 6163573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 31676201 — intervention group
Group type: EXPERIMENTAL
Intervention: Action planning
Number of subjects: 100
Study 31676201 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance‐based
Number of subjects: 100
Study 31676201 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflection
Number of subjects: 100
Study 31443815 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes education plus stress management
Number of subjects: 121
Study 31443815 — intervention group
Group type: COMPARATOR
Intervention: Diabetes education
Number of subjects: 121
Study 29017395 — intervention group
Group type: EXPERIMENTAL
Intervention: EABhigh
Number of subjects: 15
Study 29017395 — intervention group
Group type: EXPERIMENTAL
Intervention: EABlow
Number of subjects: 15
Study 29017395 — intervention group
Group type: COMPARATOR
Intervention: Classical cycling
Number of subjects: 15
Study 26817505 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 15
Study 26817505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 25305053 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimney stove
Number of subjects: 132
Study 25305053 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined maternal/infant null GSTT1
Number of subjects: 132
Study 25305053 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressed GST genes
Number of subjects: 132
Study 25305053 — intervention group
Group type: COMPARATOR
Intervention: Open fires for cooking
Number of subjects: 132
Study 22946606 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Well health promotion program
Number of subjects: 297
Study 22946606 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 297
Study 20482399 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone and Azathioprine (AZA)
Number of subjects: 21
Study 20482399 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone and Cyclosporine (CyA)
Number of subjects: 21
Study 18361314 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 300 mg daily
Number of subjects: 28
Study 18361314 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine 2 x 250 mg daily
Number of subjects: 28
Study 18361314 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ASA and ticlopidine
Number of subjects: 28
Study 16253799 — intervention group
Group type: COMPARATOR
Intervention: Standard tube feeding formula (n=14)
Number of subjects: 30
Study 16253799 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula acidified using potassium sorbate to a pH of 4.25 (n=16)
Number of subjects: 30
Study 16253799 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 11850161 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (2 g/0.5 g/q8h)
Number of subjects: 237
Study 11850161 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin (0.5 g/0.5 g/q8h)
Number of subjects: 237
Study 10486669 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP < or = 80 mmHg
Number of subjects: 922
Study 10486669 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP < or = 85 mmHg
Number of subjects: 922
Study 10486669 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP < or = 90 mmHg
Number of subjects: 922
Study 9180976 — intervention group
Group type: EXPERIMENTAL
Intervention: Curare (AC) group with atracurium 0.25 mg.kg‐1 for intubation
Number of subjects: 50
Study 9180976 — intervention group
Group type: COMPARATOR
Intervention: Control group without curare (SC)
Number of subjects: 50
Study 1721171 — intervention group
Group type: EXPERIMENTAL
Intervention: Autodecremental burst pacing
Number of subjects: 22
Study 1721171 — intervention group
Group type: EXPERIMENTAL
Intervention: Decremental scanning
Number of subjects: 22
Study 7131542 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational materials (posters, recipes, brochures) placed in the dairy section for 6 months
Number of subjects: 8
Study 7131542 — intervention group
Group type: COMPARATOR
Intervention: No educational materials (control condition)
Number of subjects: 8
Study 30630533 — intervention group
Group type: EXPERIMENTAL
Intervention: CT data-based 3D pelvic model measurement of pelvic incidence (PI)
Number of subjects: 320
Study 30389581 — intervention group
Group type: EXPERIMENTAL
Intervention: Dancing
Number of subjects: 30
Study 30389581 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 30
Study 30389581 — intervention group
Group type: COMPARATOR
Intervention: Stretching (active control)
Number of subjects: 30
Study 30389581 — intervention group
Group type: COMPARATOR
Intervention: All groups (Dancing, Walking, Stretching)
Number of subjects: 30
Study 26845715 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propranolol (0.5 mg/kg/dose q8h)
Number of subjects: 47
Study 26845715 — intervention group
Group type: COMPARATOR
Intervention: Historic control group
Number of subjects: 47
Study 24934009 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative interactive groups
Number of subjects: 0
Study 24934009 — intervention group
Group type: COMPARATOR
Intervention: Nominal groups
Number of subjects: 0
Study 22494488 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinto beans/rice
Number of subjects: 17
Study 22494488 — intervention group
Group type: EXPERIMENTAL
Intervention: Black beans/rice
Number of subjects: 17
Study 22494488 — intervention group
Group type: EXPERIMENTAL
Intervention: Red kidney beans/rice
Number of subjects: 17
Study 22494488 — intervention group
Group type: COMPARATOR
Intervention: Rice alone (control)
Number of subjects: 17
Study 21048536 — intervention group
Group type: COMPARATOR
Intervention: Steroid group (n=54)
Number of subjects: 110
Study 21048536 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-free immunosuppression
Number of subjects: 110
Study 21048536 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-free group (n=56)
Number of subjects: 110
Study 21048536 — intervention group
Group type: COMPARATOR
Intervention: HCV patients
Number of subjects: 110
Study 21048536 — intervention group
Group type: COMPARATOR
Intervention: Steroid bolus therapy
Number of subjects: 110
Study 17932357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen use (yes)
Number of subjects: 377
Study 17932357 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 377
Study 17932357 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at diagnosis (≥65 versus <65)
Number of subjects: 377
Study 16320746 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus drug (group D)
Number of subjects: 477
Study 16320746 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (group A)
Number of subjects: 477
Study 16320746 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (group B)
Number of subjects: 477
Study 16320746 — intervention group
Group type: COMPARATOR
Intervention: Drug (group C)
Number of subjects: 477
Study 16320746 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture plus drug (group E)
Number of subjects: 477
Study 12220425 — intervention group
Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy with diaphragm opening
Number of subjects: 20
Study 12220425 — intervention group
Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy without diaphragm opening
Number of subjects: 20
Study 12220425 — intervention group
Group type: COMPARATOR
Intervention: Transhiatal esophagectomy (both groups)
Number of subjects: 20
Study 11922399 — intervention group
Group type: EXPERIMENTAL
Intervention: Cizolirtine 200 mg administered twice daily for 21 days
Number of subjects: 25
Study 11922399 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered twice daily for 21 days
Number of subjects: 25
Study 11922399 — intervention group
Group type: EXPERIMENTAL
Intervention: Cizolirtine
Number of subjects: 25
Study 11922399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 9550651 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) induction
Number of subjects: 89
Study 8311269 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 5 micrograms/kg combined with thiopental 3 mg/kg, maintained with isoflurane and fentanyl 0.02 microgram.kg‐1.min‐1
Number of subjects: 27
Study 8311269 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 2 mg/kg combined with thiopental 3 mg/kg, maintained with isoflurane and ketamine 20 micrograms.kg‐1.min‐1
Number of subjects: 27
Study 8311269 — intervention group
Group type: COMPARATOR
Intervention: Thiopental 5 mg/kg, maintained with isoflurane only
Number of subjects: 27
Study 3353456 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised home exercise program
Number of subjects: 14
Study 3353456 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no exercise program)
Number of subjects: 14
Study 3353456 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-limited multistage step test
Number of subjects: 14
Study 3353456 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Respiratory Disease Questionnaire
Number of subjects: 14
Study 5303551 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbuffered aspirin ingestion with alcohol
Number of subjects: 20
Study 5303551 — intervention group
Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 20
Study 392094 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 125 mg b.i.d.
Number of subjects: 50
Study 392094 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 250 mg b.i.d.
Number of subjects: 50
Study 392094 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg b.i.d.
Number of subjects: 50
Study 392094 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids (prednisone)
Number of subjects: 50
Study 30185239 — intervention group
Group type: EXPERIMENTAL
Intervention: web-based CBT-I
Number of subjects: 56
Study 30185239 — intervention group
Group type: COMPARATOR
Intervention: waiting-list control
Number of subjects: 56
Study 30006474 — intervention group
Group type: EXPERIMENTAL
Intervention: E-Counseling
Number of subjects: 264
Study 30006474 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 264
Study 27455604 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard diet plus two drinks per day containing 4 g inulin, 4 mg menthol, and 2 mg pyridoxine for 2 weeks
Number of subjects: 49
Study 24369301 — intervention group
Group type: EXPERIMENTAL
Intervention: SUCCEED (six-month lifestyle intervention)
Number of subjects: 75
Study 24369301 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 75
Study 21440444 — intervention group
Group type: EXPERIMENTAL
Intervention: Retransfusion Drain
Number of subjects: 48
Study 21440444 — intervention group
Group type: COMPARATOR
Intervention: No Drain
Number of subjects: 48
Study 21047432 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic online weight-loss program
Number of subjects: 3
Study 21047432 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced online weight-loss program
Number of subjects: 3
Study 21047432 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 3
Study 21047432 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance basic program
Number of subjects: 3
Study 21047432 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance enhanced program
Number of subjects: 3
Study 21047432 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 3
Study 15578008 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 0
Study 15578008 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral analysis system of psychotherapy (CBASP)
Number of subjects: 0
Study 15578008 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nefazodone and CBASP
Number of subjects: 0
Study 11820489 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10430731 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled low-molecular-weight heparin (enoxaparin) 0.5 mg/kg
Number of subjects: 13
Study 10430731 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled low-molecular-weight heparin (enoxaparin) 1 mg/kg
Number of subjects: 13
Study 10430731 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled low-molecular-weight heparin (enoxaparin) 2 mg/kg
Number of subjects: 13
Study 10430731 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled unfractionated heparin (7.5 mg/kg)
Number of subjects: 13
Study 10430731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 10430731 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 13
Study 7985890 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (thyroid‐stimulating hormone level, < 0.3 mU/L)
Number of subjects: 80
Study 7985890 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium iodide (2 mg every 2 weeks)
Number of subjects: 80
Study 7985890 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 80
Study 2111415 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC + FT + Bestatin
Number of subjects: 96
Study 2111415 — intervention group
Group type: COMPARATOR
Intervention: MMC + FT
Number of subjects: 96
Study 6778352 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane with nitrous oxide (N2O)
Number of subjects: 69
Study 6778352 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane without nitrous oxide (N2O)
Number of subjects: 69
Study 6778352 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted ventilation during mask inhalation anesthetic techniques
Number of subjects: 69
Study 31808611 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep lamellar dissection (scleral flap excision)
Number of subjects: 32
Study 31808611 — intervention group
Group type: COMPARATOR
Intervention: Vertical cut‐down incision
Number of subjects: 32
Study 28724370 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural and psychoeducational intervention (five sessions, four hours each)
Number of subjects: 20
Study 28724370 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 26296850 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark chocolate (49 g/day) during reduced snack consumption
Number of subjects: 22
Study 26296850 — intervention group
Group type: COMPARATOR
Intervention: Control (reduced snacks only)
Number of subjects: 22
Study 25108751 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic flexion-distraction manipulation (8 treatments)
Number of subjects: 60
Study 25108751 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic flexion-distraction manipulation (12 treatments)
Number of subjects: 60
Study 25108751 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic flexion-distraction manipulation (18 treatments)
Number of subjects: 60
Study 25108751 — intervention group
Group type: COMPARATOR
Intervention: Placebo care (8 treatments)
Number of subjects: 60
Study 21964953 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week service learning activities
Number of subjects: 124
Study 21964953 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 124
Study 19608997 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide (100-200 mg daily for up to 2 years)
Number of subjects: 724
Study 19608997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 724
Study 17844713 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0
Study 17844713 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy
Number of subjects: 0
Study 17844713 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy followed by transfer for PCI
Number of subjects: 0
Study 15354209 — intervention group
Group type: EXPERIMENTAL
Intervention: IM862 (20 mg intranasally three times daily for 8 weeks)
Number of subjects: 25
Study 12398962 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg/day
Number of subjects: 1092
Study 12398962 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 200 mg/day
Number of subjects: 1092
Study 10423978 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions consistent with corresponding RCT data
Number of subjects: 197
Study 10423978 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions in cardiology, stroke/angiology, and gastroenterology
Number of subjects: 197